Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Lexaria Bioscience (LEXX) over the last 3 years, with Q4 2025 value amounting to -$5744.0.

  • Lexaria Bioscience's Exchange Rate Effect fell 8091.34% to -$5744.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$53088.0, marking a year-over-year decrease of 9401.38%. This contributed to the annual value of -$50519.0 for FY2025, which is 15494.05% down from last year.
  • Per Lexaria Bioscience's latest filing, its Exchange Rate Effect stood at -$5744.0 for Q4 2025, which was down 8091.34% from $10738.0 recorded in Q3 2025.
  • Over the past 5 years, Lexaria Bioscience's Exchange Rate Effect peaked at $37173.0 during Q2 2025, and registered a low of -$95255.0 during Q1 2025.
  • Over the past 3 years, Lexaria Bioscience's median Exchange Rate Effect value was -$1240.0 (recorded in 2024), while the average stood at -$8453.2.
  • Examining YoY changes over the last 5 years, Lexaria Bioscience's Exchange Rate Effect showed a top increase of 309782.26% in 2025 and a maximum decrease of 28105.05% in 2025.
  • Over the past 3 years, Lexaria Bioscience's Exchange Rate Effect (Quarter) stood at $4372.0 in 2023, then plummeted by 172.62% to -$3175.0 in 2024, then tumbled by 80.91% to -$5744.0 in 2025.
  • Its Exchange Rate Effect stands at -$5744.0 for Q4 2025, versus $10738.0 for Q3 2025 and $37173.0 for Q2 2025.